Top Markets
Coin of the day
OmniAb, Inc. OmniAb, Inc.

OmniAb, Inc.

OABI
Classement en actions #11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Prix de l'action
$4.48
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$649.33M
Changement (1 jour)
-2.84%
Changement (1 an)
179.94%
Pays
US
Échange OmniAb, Inc. (OABI)

Catégorie

Historique des divisions d’actions pour OmniAb, Inc. (OABI)
L’action OmniAb, Inc. (symbole : OABI) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 30, 2026.
Une action OABI achetée avant le Aug 30, 2026 équivaudrait aujourd’hui à 0 actions OABI.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH